Rivaroxaban is a direct oral anticoagulant (DOAC) that effectively thins the blood to prevent and treat potentially dangerous blood clots. It is widely prescribed to lower the risk of stroke in patients with non-valvular atrial fibrillation and to treat deep vein thrombosis (DVT) and pulmonary embolism (PE).